Klaria Pharma
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar! Klaria Annual Report 2024
REG
The year in brief
- Net sales amounted to 2.2 MSEK (8.5 MSEK)
- Other operating income amounted to 0.1 MSEK (0.5 MSEK)
- R&D costs amounted to 22.1 MSEK (25.0 MSEK)
- Profit/loss after tax amounted to -47.8 MSEK (-35.8 MSEK)
- Earnings per share amounted to -0.38 SEK (-0.36 SEK)
- Cash flow from operations amounted to -11.9 MSEK (-9.1 MSEK)
- Shareholder’s equity as of December 31, 2024 amounted to 3.3 MSEK (41.1 MSEK)
- Cash and cash equivalents as of December 31, 2024 amounted to 0.6 MSEK (1.2 MSEK)
| Datum | 2025-04-30, kl 11:00 |
| Källa | Cision |